Compare POWI & PRGO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | POWI | PRGO |
|---|---|---|
| Founded | 1988 | 1887 |
| Country | United States | Ireland |
| Employees | N/A | N/A |
| Industry | Semiconductors | Biotechnology: Pharmaceutical Preparations |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.0B | 1.8B |
| IPO Year | 1997 | 1991 |
| Metric | POWI | PRGO |
|---|---|---|
| Price | $36.22 | $13.47 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 3 | 4 |
| Target Price | ★ $60.00 | $22.50 |
| AVG Volume (30 Days) | 848.1K | ★ 4.1M |
| Earning Date | 11-05-2025 | 11-05-2025 |
| Dividend Yield | 2.36% | ★ 8.63% |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 0.32 | N/A |
| Revenue | $445,550,000.00 | ★ $4,281,800,000.00 |
| Revenue This Year | $7.93 | N/A |
| Revenue Next Year | $7.60 | N/A |
| P/E Ratio | $114.85 | ★ N/A |
| Revenue Growth | ★ 10.49 | N/A |
| 52 Week Low | $30.86 | $12.17 |
| 52 Week High | $68.20 | $30.93 |
| Indicator | POWI | PRGO |
|---|---|---|
| Relative Strength Index (RSI) | 50.99 | 32.48 |
| Support Level | $32.81 | $13.34 |
| Resistance Level | $33.93 | $14.12 |
| Average True Range (ATR) | 1.32 | 0.47 |
| MACD | 0.70 | 0.34 |
| Stochastic Oscillator | 84.46 | 66.41 |
Power Integrations Inc designs, develops, and markets analog and mixed-signal integrated circuits (ICs) and other electronic components and circuitry used in high-voltage power conversion. Products are used in power converters that convert electricity from a high-voltage source to the type of power required for a specified downstream use. Products are used in electronic products including mobile phones, computing and networking equipment, appliances, electronic utility meters, battery-powered tools, industrial controls, home automation, or Internet of Things applications such as networked thermostats, power strips, and security devices. Geographically, the company generates maximum revenue from China and Hong Kong.
Perrigo is one of the largest consumer health companies in the world. Since 2018, Perrigo divested its animal health and generic pharmaceuticals businesses to solely focus on consumer self-care. In North America (two thirds of total sales), the firm's product mix is anchored in private-label consumer health goods, which are sold to major retailers like Walmart, Amazon, Costco, and CVS. Perrigo also plays in Europe, Australia, and parts of Asia where it primarily generates revenue through its national brands, including Compeed, Solpadeine, Coldrex, and ellaOne.